Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia

Gruppo Italiano Malattie EMatologiche dell'Adulto is conducting this study to determine if the use of TPO agonists (specifically eltrombopag and romiplostim) can cause a sustained or persistent remission in adults patients with either persistent or chronic ITP who have failed to respond to at least one other therapy.

Italy

https://www.clinicaltrials.gov/ct2/show/NCT02298075?recrs=ab&cond=Immune+Thrombocytopenia&draw=2&rank=3

Recruiting

back to top

BBB Cleveland logo GuideStar Seal NORD Member Badge 2018THSNA logo